Pharmaceutical Industry News
IoTroducing Smart Devices and the Internet of Things
The Internet of Things (known to its friends as IoT) is the collective name given to devices which contain computer […]
Jun 26th, 2022
The role of single-use technologies in vaccine development will continue to evolve over the next decade, according to Xavier Derouck of GlaxoSmithKline.
GSK is a “great believer” in single-use systems, Mr Derouck told delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
To ensure single-use technologies are “used to produce vaccines without any risk” to patients, robust risk mitigation strategies needed to be implemented across all rungs of the supply chain, he added.
As such, Mr Derouck forecasted that over the next five to ten years single-use systems would continue moving towards:
Mr Derouck is GSK’s global senior sourcing manager for single-use technology.